Page 291 - Read Online
P. 291

Ghosh et al. Neuroimmunol Neuroinflammation 2018;5:38         Neuroimmunology and
               DOI: 10.20517/2347-8659.2018.28                                   Neuroinflammation




               Original Article                                                              Open Access


               Predictors of severity and outcome and roles of
               intravenous thrombolysis and biomarkers in first
               ischemic stroke


               Kartick Chandra Ghosh, Ramesh Bhattacharya, Saikat Ghosh, Manoj Mahata, Sarbajit Das,
               Suman Das, Gourango Prosad Mondal
               Department of Neurology, Calcutta National Medical College, Kolkata PIN-700014, India.

               Correspondence to: Dr. Suman Das, Department of Neurology, Calcutta National Medical College, Kolkata PIN-700014, India. E-mail:
               dr.sumands@gmail.com

               How to cite this article: Ghosh KC, Bhattacharya R, Ghosh S, Mahata M, Das S, Das S, Mondal GP. Predictors of severity and
               outcome and roles of intravenous thrombolysis and biomarkers in first ischemic stroke. Neuroimmunol Neuroinflammation
               2018;5:38. http://dx.doi.org/10.20517/2347-8659.2018.28

               Received: 16 May 2018     First Decision: 14 Aug 2018     Revised: 20 Aug 2018     Accepted: 22 Aug 2018      Published: 27 Sep 2018
               Science Editor: Athanassios P. Kyritsis    Copy Editor: Yuan-Li Wang    Production Editor: Huan-Liang Wu




               ABSTRACT
               Aim: Stroke is one of the leading causes of death and disability. The proportion of patients receiving recombinant
               tissue plasminogen activator is low in our country. Biomarkers to identify patients at risk of severe disease, and
               guide treatment and prognosis would be valuable. This article aims to identify the factors that can independently
               prognosticate the acute phase of ischemic stroke.


               Methods: All patients with the first episode of ischemic stroke admitted to the Neurology Department between
               1st December 2017 to 31st March 2018 were included in this pilot study. Stroke severity was evaluated using the
               National Institute of Health Stroke Scale (NIHSS). Patients being admitted within 4.5 h of onset of symptoms were
               thrombolysed with injection alteplase. For each patient, 4 serum biomarkers (D-dimer, fibrinogen, C-reactive pro-
               tein and neuron specific enolase) were evaluated at admission and 24 h later. Discharged patients were assessed on
               an outpatient basis using the modified Rankin scale. The study primarily aimed to identify the factors predicting the
               severity and outcome of stroke, and to evaluate the effect of thrombolysis on the outcome. The secondary aim was
               to evaluate the role of biomarkers to predict the unfavorable outcome and the chance of post thrombolysis hemor-
               rhage.


               Results: Out of 30 patients included in the study, 10 had NIHSS 0-4, 12 had NIHSS 5-15 and 8 had NIHSS 16-42.
               Sixteen patients had unfavorable outcome (mRS score ≥ 2), and 5 patients expired. Old age, history of diabetes,
               CHADS2 score ≥ 2, and total anterior circulation stroke (TACS) independently affected stroke severity, whereas low


                           © The Author(s) 2018. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
                sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long
                as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
                and indicate if changes were made.


                                                                                                                                                      www.nnjournal.net
   286   287   288   289   290   291   292   293   294   295   296